Introduction: Aorto-iliac occlusive disease can cause disabling symptoms and Trans-Atlantic Inter-Society Consensus (TASC II) has recommended the treatment options for varying severity of the disease. In the TASC II article, an increasing interest for laparoscopic aorto-ilio-femoral surgery was noted.
Aim: To review the literature on the minimally invasive interventions currently used in aorto-iliac occlusive disease with a focus on laparoscopic aortic surgery.
Methods: Medline search and hand search of references from relevant articles to describe the current management options for aorto-iliac occlusive disease.
Conclusion: Laparoscopic aorto-femoral surgery is a therapeutic option for most TASC C and D lesions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/SLE.0b013e3181a6f349 | DOI Listing |
Introduction: In 2015, Society for Vascular Surgery guidelines on claudication management were released spanning optimal medical management, procedural, and post-procedure recommendations. Uptake of guidelines and changes to clinical practice over time remain unknown. This study hypothesized that guideline aligned practice increased after guideline release.
View Article and Find Full Text PDFVascular
December 2024
Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, Harapan Kita National Cardiovascular Center, Jakarta, Indonesia.
Background: Endovascular intervention by means of thrombolysis is emerging as a promising management of Acute Aortic Occlusion (AAO). This study aims to evaluate the outcomes of endovascular thrombectomy for AAO cases in a single-center tertiary hospital in Indonesia.
Methods: We review retrospectively AAO patients treated by Rheolytic thrombectomy ± stenting or TEVAR at our referral center from 2011 to 2024.
Vasc Endovascular Surg
October 2024
Department of Cardiovascular Surgery, Mayo Clinic Health System, Eau Claire, WI, USA.
J Clin Med
September 2024
Vascular and Endovascular Surgery Unit, S. Maria della Misericordia University Hospital, 06132 Perugia, Italy.
: In recent years, manufacturers have developed new low-profile stent grafts to allow endovascular treatment of abdominal aortic aneurysms (AAA) in patients with small access vessels. We evaluated the early and mid-term outcomes of the Incraft (Cordis Corp, Bridgewater, NJ, USA) ultra-low profile endograft implantation in a high-volume single center. : Between 2014 and 2023, 133 consecutive endovascular aneurysm repair (EVAR) procedures performed using the Incraft endograft were recorded in a prospective database.
View Article and Find Full Text PDFIntroduction: Peripheral arterial disease (PAD) is a critical concern, particularly in the context of an aging population and escalating risk factors such as diabetes, hypertension, and smoking. PAD leads to significant morbidity and disability, imposing considerable healthcare and economic burdens. A detailed understanding of the functional outcomes of revascularization is essential as it influences the choice of therapeutic strategies.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!